CDC42 and gastric cancer: Research indicates that the atypical Rho GEF DOCK6 facilitates the proliferation, migration, and invasion of gastric cancer cells while also enhancing chemo- and radio-resistance via the DOCK6/Rac1/Cdc42 axis and the DOCK6/WNT/β-catenin signaling pathway [45, 46].